Abstract:OBJECTIVE:Genome-wide association studies have linked variants of fat mass and obesity-associated protein (FTO) to obesity. However, the molecular function of FTO remains unclear. In this study, we sought to investigate the potential effects of FTO in modulating cholesterol deposition in macrophage foam cells, as well as whether FTO exerts antiatherosclerotic properties in apolipoprotein E-deficient mice. METHOD AND RESULTS:We transfected RAW264.7 cells with plasmids encoding a wild-type or mutant FTO gene (I367F). The upregulation of FTO markedly attenuated cholesterol ester accumulation in macrophages loaded with oxidized LDL, whereas the downregulation of FTO reversed this effect. Moreover, FTO attenuated the mRNA and protein expression of a scavenger receptor, CD36, which was accompanied by the decline of peroxisome proliferator-activated receptor γ protein. In addition, FTO enhanced the phosphorylation of AMP-activated protein kinase (AMPK)α and acetyl-CoA carboxylase, which was effectively suppressed by FTO small interfering RNA. Pretreatment with compound C or transfection with a dominant-negative AMPKα blocked the FTO-mediated upregulation of ATP-binding cassette transporter A1 and ATP-binding cassette transporter G1. Furthermore, FTO suppressed IL-1β secretion independent of the activation of the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 inflammasome. In-vivo experiments were performed using apolipoprotein E-deficient mice that were infected with adeno-associated virus serotype 9-derived vectors encoding a wild-type or mutant FTO gene. FTO overexpression prevented the formation of atherosclerotic plaques and markedly reduced the content of plasma total cholesterol and LDL cholesterol. Notably, the antiatherosclerotic properties of FTO were observed only in male mice. CONCLUSION:We propose that the FTO-dependent control of cholesterol deposition may provide avenues for the treatment of atherosclerosis.

FTO Gene: a New Target for Obesity Treatment

Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases

FTO gene polymorphisms and obesity risk in Chinese population: a meta-analysis

Research Progress in FTO Gene and Obesity

Roles of FTO Gene in Tumor Metabolism

Regulation of Fat Mass and Obesity Associated Gene in Animal Fat Metabolism：A Review

Polymorphism in 5 ' Regulatory Region of the Porcine Fat Mass and Obesity Associated (fto) Gene is Associated with Intramuscular Fat Content in A Jinhua X Pietrain F-2 Reference Population

Research Advance of the Relationship between Fat Mass and Obesity Associated Gene and Obesity

FTO – A Common Genetic Basis for Obesity and Cancer

<i>FTO </i>genotype and body mass index reduction in childhood obesity interventions: A systematic review and meta-analysis

FTO is a Transcriptional Repressor to Auto-Regulate Its Own Gene and Potentially Associated with Homeostasis of Body Weight.

Fat mass and obesity-associated gene expression and its biological function in colon cancer tissues

The ‘Fat Mass and Obesity Related’ (FTO) gene: Mechanisms of Impact on Obesity and Energy Balance

The Fto Gene Regulates the Proliferation and Differentiation of Pre-Adipocytes in Vitro

Fat Mass and Obesity Associated (FTO) Gene and Hepatic Glucose and Lipid Metabolism

The Fat Mass and Obesity Associated Gene Fto Functions in the Brain to Regulate Postnatal Growth in Mice

The Role of FTO Risk Haplotype in Overweight/Obesity and Lipid Parameters‐Results From the Central China Population Study

The Role of FTO in Tumors and It's Research Progress.

FTO genotype and body mass index reduction in childhood obesity interventions: A systematic review and meta‐analysis

Fat mass and obesity-associated protein attenuates lipid accumulation in macrophage foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice.

Fat Mass and Obesity-Associated Gene Enhances Oxidative Stress and Lipogenesis in Nonalcoholic Fatty Liver Disease.